August 24, 2016 — Guided Therapeutics Inc. announced in late July that it has sold the first LuViva Advanced Cervical Scan to its distributor in Russia.
The LuViva will be used for marketing clinical studies and for testing as part of the approval process by the Russian Federal Service for Control over Healthcare and Social Development, more commonly known as "Roszdravnadzor." Approval is expected in 2017.